The 25 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 95.00, with a high estimate of 110.00 and a low estimate of 75.00. The median estimate represents a +36.49% increase from the last price of 69.60.
The current consensus among 30 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.63
Reporting Date Oct 25
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.